Elevated prolactin levels in bronchogenic carcinoma.
作者信息
Davis S, Proper S, May P B, Ertel N H
出版信息
Cancer. 1979 Aug;44(2):676-9. doi: 10.1002/1097-0142(197908)44:2<676::aid-cncr2820440239>3.0.co;2-d.
Abstract
The frequency and significance of hyperprolactinemia was studied in 21 consecutive, untreated male patients with bronchogenic carcinoma. Seven patients (33%) were found to have elevated serum prolactin (hPRL) levels. No correlation was demonstrated between increased hPRL levels, tissue histology, or tumor burden. L-dopa suppression and/or TRH stimulation tests were obtained in three untreated patients with hyperprolactinemia. The results of these tests were considered normal suggesting hypothalamic control.
摘要
相似文献
1
Elevated prolactin levels in bronchogenic carcinoma.
Cancer. 1979 Aug;44(2):676-9. doi: 10.1002/1097-0142(197908)44:2<676::aid-cncr2820440239>3.0.co;2-d.
2
Circulating hormones in lung cancer.
Indian J Med Res. 1984 May;79:636-40.
3
Infrequent elevation of plasma ACTH in patients with bronchogenic carcinoma.
Am J Med Sci. 1982 Jan-Feb;283(1):2-7. doi: 10.1097/00000441-198201000-00001.
4
Ectopic hormones in lung cancer patients at diagnosis and during therapy.
Cancer. 1980 Jul 15;46(2):347-54. doi: 10.1002/1097-0142(19800715)46:2<347::aid-cncr2820460223>3.0.co;2-s.
5
Fibrinolysis in human bronchogenic carcinoma.
Bibl Anat. 1975;13:315-6.
6
Tissue polypeptide antigen in bronchogenic carcinoma.
Neoplasma. 1993;40(5):301-3.
7
Increased serum calcitonin levels in bronchogenic cancer.
Chest. 1976 Apr;69(4):495-9. doi: 10.1378/chest.69.4.495.
8
Circulating blood RNA in lung cancer.
J Assoc Physicians India. 1986 Aug;34(8):579-80.
9
Dissociation of thyrotropin and prolactin responsiveness to thyrotropin releasing hormone stimulation in L-dopa treated parkinsonian patients.
Horm Res. 1981;15(2):78-87. doi: 10.1159/000179437.
10
Blood coagulation and fibrinolysis in patients with carcinoma of the lung.
J Med. 1973;4(2):96-105.
Zotero 插件